Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Labels:

Popular posts in the last week

Opportunities for the Euro and Yuan

Internationalism No. 77, July 2025 Page 13 Estimates by international institutions for April to June confirm the slowdown in global output and trade. The World Bank forecasts a decline in GDP growth from 2.8% in 2024, to 2.3% in 2025, and a sharp fall in trade from 3.4% to 1.8%. The main cause of the new slowdown is the tariff war declared by Donald Trump, who has so far imposed a universal minimum tariff of 10%. The uncertainty arising from his peculiar art of the deal , consisting of lunges, postponements, relaunches, U-turns, and pauses, makes the policy of the world's leading power unpredictable. It is also paying the highest price, with US growth halving, from 2.8% to 1.4%. The Eurozone has been floating at a rate of less than 1% since 2023 and, according to the World Bank, will remain below this level in 2025 and 2026, while the OECD and the ECB predict a return to 1% in 2025. Chin...
Read more

Libertarian Communism: A Different Kind of Communism

Chapter Three LIBERTARIAN COMMUNISM: A DIFFERENT KIND OF COMMUNISM   An examination of the debate within the groups that were to create GAAP (Anarchist Groups of Proletarian Action) gives a vivid picture of the problems that between 1948 and 1951 had to be slowly and painfully faced. Three major confrontations, progressively more serious, took place between Cervetto and Masini in the autumn of 1949 and again in the spring and autumn of 1950. As preparations were being made for the National Conference at Pontedecimo – from which GAAP would be born – debate on the nature of the organisation and on theories of the State and imperialism began to define the characteristics of the new political group, but also revealed the differences. The first step had been to look for ‘a different kind’ of communism in anarchism. Along this road Cervetto , with an ever-surer grasp, would raise the issue that had been first posed by Marx and Lenin : our militant...
Read more

Lotta Comunista: The Origins 1943-1952

Guido La Barbera Contents 9. Preface to the English Edition 13. Preface 19. Useful dates 21. Chapter One «ONE OUGHT TO KNOW WITH WHOM ONE IS DEALING» 25. The balance-of-power theory 27. Theory and the ‘strategy-party’ 29. Chapter Two THE FOUNDRY AND THE PARTISAN STRUGGLE 31. The Savona group 39. Passion disciplined by reason 40. Never again a tool in the hands of others 41. The Genoa group 46. The Sestri Ponente group 48. The groups in Rome and Tuscany 52. The strength of GAAP: ‘only a handful’ 55. Chapter Three LIBERTARIAN COMMUNISM: A DIFFERENT KIND OF COMMUNISM 58. Reckoning with Bordiga...
Read more

The Unitary Imperialism Issue

Chapter Six   In 1951 Europe, and the world, was shrouded in mist. The ‘Cold War’ ideology ruled, and the war in Korea made a world conflict between the USA and the USSR seem a real possibility. In France, Great Britain, Germany and Italy, the talk was of rearmament. Europe, at that time urged by the USA, was planning the EDC (European Defence Community) to keep step with German rearmament. The concept of a ‘ unitary imperialism ’ was the strategic choice that helped the small GAAP group remain politically independent. But translating this into an ‘Internationalist Third Front’ slogan was unfortunate. It facilitated a link with French libertarian communists, but could also cause confusion with its suggestion of a ‘Third Force’ between the USA and the USSR, which in Europe was supported by important bourgeois currents. Although opposition to unitary imperialism consolidated the internationalist struggle, the theory required to be developed and per...
Read more

Capitalist Chaos and Artificial Intelligence

Internationalism No. 88, June 2026 Page 1 From the series Artificial Intelligence It may seem curious that the Franciscan friar Paolo Benanti refers to neuroscience and the theories of David Eagleman, which reflect a materialistic conception of consciousness. The explanation probably lies in Eagleman’s self-definition as a possibilian , a not particularly clever neologism that seeks to distinguish itself from atheism, but also from agnosticism: we know too little, so science must keep multiple possibilities open at once. In Engels’ view, agnosticism is shamefaced materialism . The scientist, as such, is a materialist. However, outside his own field, he translates his ignorance into Greek and calls it agnosticism . Eagleman is even more circumspect, so it is understandable that religion sees an opening for itself in the possibilities left open. In Die Zeit , Benan...
Read more

Origins of Russian Nuclear Power

Internationalism No. 78-79, August-September 2025 Page 14 From the series Atoms and industrialisation of science On August 6 th , 1945, a uranium bomb was dropped on Hiroshima, and on August 9 th a plutonium bomb on Nagasaki. Contradicting the American military and political leaders’ forecasts of a ten-to-twenty-year delay, the Soviet Union tested its first nuclear bomb just four years later, in 1949. According to the world’s leading nuclear scientists, and in particular Niels Bohr [1885-1962], this was not a surprise. Having worked with Soviet scientists, they understood that their science and technology was no less competent than their own. The history of Russian nuclear science For the history of Russian nuclear power, we shall mainly follow David Holloway’s 1994 work Stalin and the Bomb , assisted by Robert Jungk’s still valid Brighter Tha...
Read more

The Four Petrochemical Giants

Internationalism No. 86, April 2026 Page 15 From the series Major industrial groups in China When the People's Republic of China was founded in 1949, oil extraction in the country was practically non-existent, and the country was completely dependent on imports. The exploration and development of domestic oil resources required a major effort. As Jin Zhang reports in his book Catch-up and Competitiveness in China [Routledge, 2004]: The required massive human resources were supplied by the People's Liberation Army (PLA). In 1952, Mao Zedong ordered the reorganisation of the 57 th Division of the 19 th Army of the PLA into the 1 st Division of Oil . The effort led to the discovery of several oil fields, the most significant of which was in Daqing, Heilongjiang Province, in northeastern China, in 1959. It became operational the following year, reaching a ...
Read more

The Foundry and the Partisan Struggle

Chapter Two   What forces were there for starting again, at the end of the 1940s? At the beginning of that road, you could count the core groups on the fingers of one hand: Genoa, its Sestri Ponente district, Savona, Rome. Of course, there were also Turin, Vicenza, Bologna, Milan, Bolzano, Trieste, Livorno, and a few sympathisers down South, but that was all it amounted to. Although there were periodic attempts at ‘linking up’ along the whole length of the peninsula, apart from the three Ligurian groups and the Tuscany-Lazio one, there wasn’t much more than a network of individual sympathisers. The Savona group Arrigo Cervetto , founder of Lotta Comunista and its undisputed leader until his death in 1995, was born in Buenos Aires in 1927, to a family who had emigrated from Savona. Returning to Liguria, he started work when still a boy, and in 1943 was taken on as an apprentice at the Ilva steel-making plant in Savona. The party ar...
Read more

Bombs Over Tehran and Tel Aviv

Internationalism No. 77, July 2025 Page 10 The crisis between Israel and Iran, which began on June 13 th , took a qualitative leap with the American decision to strike three uranium enrichment sites just ten days later. The attacks were carried out with cruise missiles and strategic bombers and, at the Fordow site, which is buried under more than 100 metres of rock, four teen of the so-called MOABs (the mother of all bombs ) were used. This is the most powerful conventional weapon in the US arsenal. In 2017, Donald Trump authorized its use in Afghanistan against an Islamic State base. American military doctrine also provides for the use of tactical nuclear weapons for the same type of mission. In any case, writes the Beijing-based Global Times , Washington has set a dangerous precedent by attacking nuclear sites in a country that is a signatory to the NPT, the Non-Proliferation Treaty, with...
Read more

The Biopharmaceutical Industry Looks to the East

Internationalism No. 77, July 2025 Page 14 From the series Industry and pharmaceuticals The 20 th century, particularly its second half, saw an extraordinary transformation in the field of pharmaceuticals. Starting with the production of penicillin, the first in a long line of antibiotics, the therapeutic capabilities of thousands of chemical compounds have been discovered, capable of changing the natural history of many diseases – that is, their normal course if left untreated. Industrial production has filled pharmacy shelves with ready-to-use remedies, or purported remedies, replacing the pharmacist’s ancient galenic formulations. Italy’s regulatory agency, Agenzia Italiana del Farmaco (AIFA), lists approximately 3,000 active ingredients across various therapeutic classes, for nearly 11,000 human medicines authorised for sale. However, we should not forget that, ...
Read more